163 related articles for article (PubMed ID: 1328844)
1. Cloning and pharmacological characterization of a novel human 5-hydroxytryptamine1D receptor subtype.
Veldman SA; Bienkowski MJ
Mol Pharmacol; 1992 Sep; 42(3):439-44. PubMed ID: 1328844
[TBL] [Abstract][Full Text] [Related]
2. Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
Zgombick JM; Weinshank RL; Macchi M; Schechter LE; Branchek TA; Hartig PR
Mol Pharmacol; 1991 Dec; 40(6):1036-42. PubMed ID: 1758439
[TBL] [Abstract][Full Text] [Related]
3. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
Zgombick JM; Schechter LE; Macchi M; Hartig PR; Branchek TA; Weinshank RL
Mol Pharmacol; 1992 Aug; 42(2):180-5. PubMed ID: 1513320
[TBL] [Abstract][Full Text] [Related]
4. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
[TBL] [Abstract][Full Text] [Related]
5. Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
Hamblin MW; Metcalf MA
Mol Pharmacol; 1991 Aug; 40(2):143-8. PubMed ID: 1652050
[TBL] [Abstract][Full Text] [Related]
6. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
7. The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor.
Adham N; Romanienko P; Hartig P; Weinshank RL; Branchek T
Mol Pharmacol; 1992 Jan; 41(1):1-7. PubMed ID: 1732716
[TBL] [Abstract][Full Text] [Related]
8. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.
Kursar JD; Nelson DL; Wainscott DB; Cohen ML; Baez M
Mol Pharmacol; 1992 Oct; 42(4):549-57. PubMed ID: 1331748
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
Pauwels PJ; Wurch T; Palmier C; Colpaert FC
Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
[TBL] [Abstract][Full Text] [Related]
11. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
Witt-Enderby PA; Dubocovich ML
Mol Pharmacol; 1996 Jul; 50(1):166-74. PubMed ID: 8700109
[TBL] [Abstract][Full Text] [Related]
12. The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor.
Cerutis DR; Hass NA; Iversen LJ; Bylund DB
Mol Pharmacol; 1994 Jan; 45(1):20-8. PubMed ID: 8302276
[TBL] [Abstract][Full Text] [Related]
13. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
[TBL] [Abstract][Full Text] [Related]
14. Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries.
Hamel E; Fan E; Linville D; Ting V; Villemure JG; Chia LS
Mol Pharmacol; 1993 Aug; 44(2):242-6. PubMed ID: 8394988
[TBL] [Abstract][Full Text] [Related]
15. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW
Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.
Lovenberg TW; Erlander MG; Baron BM; Racke M; Slone AL; Siegel BW; Craft CM; Burns JE; Danielson PE; Sutcliffe JG
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2184-8. PubMed ID: 8384716
[TBL] [Abstract][Full Text] [Related]
17. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
Matthes H; Boschert U; Amlaiky N; Grailhe R; Plassat JL; Muscatelli F; Mattei MG; Hen R
Mol Pharmacol; 1993 Mar; 43(3):313-9. PubMed ID: 8450829
[TBL] [Abstract][Full Text] [Related]
18. 2-(1-Naphthyloxy)ethylamines with enhanced affinity for human 5-HT1D beta (h5-HT1B) serotonin receptors.
Ismaiel AM; Dukat M; Law H; Kamboj R; Fan E; Lee DK; Mazzocco L; Buekschkens D; Teitler M; Pierson ME; Glennon RA
J Med Chem; 1997 Dec; 40(26):4415-9. PubMed ID: 9435911
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
[TBL] [Abstract][Full Text] [Related]
20. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]